Evaluation of the Risk of NSF Following ProHance Injection in Patients With Chronic Kidney Disease

NCT00600834 · clinicaltrials.gov ↗
COMPLETED
Status
172
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Bracco Diagnostics, Inc